Patients with low HDL-cholesterol caused by mutations in LCAT have increased arterial stiffness

Atherosclerosis

Volumn 225, Issue 2, 2012, Pages 481-485

  van den Bogaard, Bas ^a   Holleboom, Adriaan G ^a   Duivenvoorden, Raphaël ^a   Hutten, Barbara A ^a   Kastelein, John J P ^a   Hovingh, G Kees ^a   Kuivenhoven, Jan Albert ^a,b   Stroes, Erik S G ^a   van den Born, Bert Jan H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Carotid femoral pulse wave velocity; Genetics; High density lipoprotein cholesterol; Intima media thickness; Lecithin:cholesterol acyl transferase; Magnetic resonance imaging

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTERIAL STIFFNESS; ARTERIAL WALL THICKENING; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MEAN ARTERIAL PRESSURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PULSE WAVE; SEX RATIO; ULTRASOUND;

ADULT; AORTA; BIOLOGICAL MARKERS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; DOWN-REGULATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LECITHIN ACYLTRANSFERASE DEFICIENCY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; PHENOTYPE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PULSE WAVE ANALYSIS; RISK FACTORS; TRIGLYCERIDES; VASCULAR STIFFNESS;

EID: 84869497153     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.09.022     Document Type: Article

References (29)

1. Gordon D.J., Probstfield J.L., Garrison R.J., et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989 Jan, 79(1):8-15.
2. Tavridou A., Ragia G., Manolopoulos V.G. Emerging targets for the treatment of dyslipidemia. Curr Med Chem 2011, 18(6):909-922.
3. Rousset X., Vaisman B., Amar M., Sethi A.A., Remaley A.T. Lecithin: cholesterol acyltransferase-from biochemistry to role in cardiovascular disease. Curr Opin Endocrinol Diabetes Obes 2009 Apr, 16(2):163-171.
4. Glomset J.A. The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res 1968 Mar, 9(2):155-167.
5. Hovingh G.K., Hutten B.A., Holleboom A.G., et al. Compromised LCAT function is associated with increased atherosclerosis. Circulation 2005 Aug 9, 112(6):879-884.
6. Calabresi L., Baldassarre D., Castelnuovo S., et al. Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans. Circulation 2009 Aug 18, 120(7):628-635.
7. Duivenvoorden R., Holleboom A.G., van den Bogaard B., et al. Carriers of lecithin cholesterol acyltransferase gene mutations have accelerated atherogenesis as assessed by carotid 3.0-T magnetic resonance imaging [corrected]. J Am Coll Cardiol 2011 Dec 6, 58(24):2481-2487.
8. Sehestedt T., Jeppesen J., Hansen T.W., et al. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J 2010 Apr, 31(7):883-891.
9. van Popele N.M., Grobbee D.E., Bots M.L., et al. Association between arterial stiffness and atherosclerosis: the Rotterdam study. Stroke 2001 Feb, 32(2):454-460.
10. Willum-Hansen T., Staessen J.A., Torp-Pedersen C., et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006 Feb 7, 113(5):664-670.
11. Laurent S., Cockcroft J., Van B.L., et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006 Nov, 27(21):2588-2605.
12. de Groot E., Hovingh G.K., Wiegman A., et al. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 2004, 109(23 Suppl. 1):33-38.
13. Czernichow S., Bertrais S., Blacher J., et al. Metabolic syndrome in relation to structure and function of large arteries: a predominant effect of blood pressure. A report from the SU.VI.MAX. Vascular study. Am J Hypertens 2005 Sep, 18(9 Pt 1):1154-1160.
14. Riggio S., Mandraffino G., Sardo M.A., et al. Pulse wave velocity and augmentation index, but not intima-media thickness, are early indicators of vascular damage in hypercholesterolemic children. Eur J Clin Invest 2010 Mar, 40(3):250-257.
15. Wang F., Ye P., Luo L., et al. Association of serum lipids with arterial stiffness in a population-based study in Beijing. Eur J Clin Invest 2011 Sep, 41(9):929-936.
16. Cecelja M., Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension 2009 Dec, 54(6):1328-1336.
17. Bisoendial R.J., Hovingh G.K., Levels J.H., et al. Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein. Circulation 2003 Jun 17, 107(23):2944-2948.
18. Krantz M.J., Long C.S., Hosokawa P., et al. Pulse wave velocity and carotid atherosclerosis in White and Latino patients with hypertension. BMC Cardiovasc Disord 2011, 11:15.
19. Taniwaki H., Kawagishi T., Emoto M., et al. Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes. Diabetes Care 1999 Nov, 22(11):1851-1857.
20. Wilkinson I.B., McEniery C.M., Cockcroft J.R. Arteriosclerosis and atherosclerosis: guilty by association. Hypertension 2009 Dec, 54(6):1213-1215.
21. Hongo M., Tsutsui H., Mawatari E., et al. Fluvastatin improves arterial stiffness in patients with coronary artery disease and hyperlipidemia: a 5-year follow-up study. Circ J 2008 May, 72(5):722-728.
22. Orr J.S., Dengo A.L., Rivero J.M., Davy K.P. Arterial destiffening with atorvastatin in overweight and obese middle-aged and older adults. Hypertension 2009 Oct, 54(4):763-768.
23. Safar M.E. Can antihypertensive treatment reverse large-artery stiffening?. Curr Hypertens Rep 2010 Feb, 12(1):47-51.
24. Calabresi L., Pisciotta L., Costantin A., et al. The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol 2005 Sep, 25(9):1972-1978.
25. Ng D.S., Xie C., Maguire G.F., et al. Hypertriglyceridemia in lecithin-cholesterol acyltransferase-deficient mice is associated with hepatic overproduction of triglycerides, increased lipogenesis, and improved glucose tolerance. J Biol Chem 2004 Feb 27, 279(9):7636-7642.
26. Vergeer M., Holleboom A.G., Kastelein J.J., Kuivenhoven J.A. The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?. J Lipid Res 2010 Aug, 51(8):2058-2073.
27. Rader D.J. Molecular regulation of HDL metabolism and function: implications for novel therapies. J Clin Invest 2006 Dec, 116(12):3090-3100.
28. Asada S., Kuroda M., Aoyagi Y., et al. Disturbed apolipoprotein A-I-containing lipoproteins in fish-eye disease are improved by the lecithin:cholesterol acyltransferase produced by gene-transduced adipocytes in vitro. Mol Genet Metab 2011 Feb, 102(2):229-231.
29. Rousset X., Vaisman B., Auerbach B., et al. Effect of recombinant human lecithin cholesterol acyltransferase infusion on lipoprotein metabolism in mice. J Pharmacol Exp Ther 2010 Oct, 335(1):140-148.